SG Americas Securities, LLC

Broker-Dealer

Position in ROIV — Roivant Sciences Ltd.

CIK 1313360 NEW YORK, NY

Position in ROIV

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$6,285,016

-$11,468,551 QoQ

Shares Held

177,593

-72.3% QoQ

Ownership

0.025%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#127

of 494 holders

Holding Since

Dec 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SG Americas Securities, LLC holds $1,085,838,933 across 181 Biotechnology names. ROIV ranks #15 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	427,703	$266,689,928
2	VRTX	Vertex Pharmaceuticals Inc / Ma	523,720	$260,147,435
3	URGN	UroGen Pharma Ltd.	2,052,906	$75,546,940
4	CGON	CG Oncology, Inc.	867,465	$61,633,388
5	PTCT	Ptc Therapeutics, Inc.	605,581	$49,397,242
6	ASND	Ascendis Pharma A/S	161,026	$42,948,854
7	RPRX	Royalty Pharma plc	688,590	$38,609,241
8	BNTX	BioNTech SE	347,131	$32,300,539

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,285,016	177,593	-72.3%	Shares	Sole	2026-08-07
2026-03-31	$17,753,567	640,923	+2651.5%	Shares	Sole	2026-04-16
2025-12-31	$505,479	23,294	-53.6%	Shares	Sole	2026-01-09
2025-09-30	$758,951	50,162	+15.6%	Shares	Sole	2025-10-23
2025-06-30	$489,129	43,401	+150.1%	Shares	Sole	2025-08-08
2025-03-31	$175,071	17,351	-42.0%	Shares	Sole	2025-04-15
2024-09-30	$345,334	29,925	-33.0%	Shares	Sole	2024-10-03
2024-06-30	$471,813	44,637	+346.4%	Shares	Sole	2024-07-12
2023-09-30	$116,788	9,999	-88.3%	Shares	Sole	2023-10-13
2023-06-30	$863,160	85,631	-8.9%	Shares	Sole	2023-07-10
2023-03-31	$693,321	93,946	+10.4%	Shares	Sole	2023-04-28
2022-12-31	$680,004	85,107	—	Shares	Sole	2023-02-02
No filing history on record for this holder in this stock.